← Leaderboards
Simona Colla
University Of Tx Md Anderson Can Ctr
$2,210,308
Attributed
$2,210,308
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $382K · FY2018–23$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,210,308 · 2
By mechanism
R01$1,831,634 · 1
R21$378,674 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Marina Y Konopleva$11,210,192
- Kapil N. Bhalla$16,921,043
- Srdan Verstovsek$1,168,238
- Courtney Dinardo$2,316,391
- Katy Rezvani$10,195,970
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeCell LineMalignant NeoplasmsSignal TransductionTargeted TreatmentValidationGene ExpressionIn VitroPhenotypeSamplingBiologicalSpliced GenesTherapeutic TargetTranslatingCellsEffective TherapyImproved OutcomeInsightMolecularClinicRecurrenceResponseDoseAnti-Cancer
Grant awards (6)
Developing an inhibitor of EIF2AK1 to overcome ineffective erythropoiesis in myelodysplastic syndromes with ringed sideroblasts$378,674
R21 · FY2023 · CA · contact PI
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma$359,657
R01 · FY2022 · CA · contact PI
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma$366,997
R01 · FY2021 · CA · contact PI
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma$366,997
R01 · FY2020 · CA · contact PI
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma$355,986
R01 · FY2019 · CA · contact PI
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma$381,997
R01 · FY2018 · CA · contact PI